促进RAS与PI3Kα结合的分子剂可以在没有胰岛素的情况下促进葡萄糖的吸收
Koji Terayama1, Shinji Furuzono1, Nicole Fer2
1Cardiovascular Metabolic Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
概括
新的分子粘合剂D223和D927通过增加酸3-激酶α (PI3Kα) 与RAS蛋白的结合亲和度来增强葡萄糖的吸收. 这些化合物有效降低血糖,改善糖尿病模型,即使没有胰岛素.
科学领域:
- 生物化学
- 药理学
- 内分泌学
背景情况:
- 糖尿病的特征是由于葡萄糖调节受损而导致高血糖.
- 目前的糖尿病治疗通常依赖于胰岛素或旨在增强其作用.
- 需要新的策略来控制血糖度,特别是在胰岛素缺乏状态下.
研究的目的:
- 为了识别促进葡萄糖吸收的新化合物,而不依赖于胰岛素.
- 阐明这些化合物具有降血糖作用的分子机制.
- 在糖尿病临床前模型中评估这些化合物的疗效.
主要方法:
- 分子D223和D927的识别和特征.
- 生物化学测试以评估PI3Kα与RAS蛋白的结合亲和力.
- 化合物与PI3KαRAS结合域的结构分析.
- 在正常和糖尿病动物模型中的体内研究 (类型1和类型2).
主要成果:
- 鉴定出D223和D927分子剂,它们可以在没有胰岛素的情况下促进葡萄糖的吸收.
- 这些化合物显著增加了PI3Kα与RAS蛋白的结合亲和力.
- 化合物D927在体内表现出类似胰岛素的作用,迅速降低血糖.
- 在包括胰岛素缺乏动物在内的1型和2型糖尿病模型中,D927改善了高血糖.
结论:
- 分子D223和D927代表一种用于调节葡萄糖的新型化合物.
- 它们的机制包括增强PI3Kα-RAS相互作用,导致胰岛素独立的葡萄糖吸收.
- 这些发现为治疗糖尿病提供了潜在的新疗法,
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Insulin: The Receptor and Signaling Pathways
1.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K
cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
MAPK Signaling Cascades
6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K


